Kendall A. Smith
Kendall A. Smith
Weill Cornell Medicine
Verified email at - Homepage
Cited by
Cited by
T cell growth factor: parameters of production and a quantitative microassay for activity
S Gillis, MM Ferm, W Ou, KA Smith
The Journal of Immunology 120 (6), 2027-2032, 1978
Interleukin-2: inception, impact, and implications
KA Smith
Science 240 (4856), 1169-1176, 1988
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
D Finzi, J Blankson, JD Siliciano, JB Margolick, K Chadwick, T Pierson, ...
Nature medicine 5 (5), 512-517, 1999
Long term culture of tumour-specific cytotoxic T cells
S Gillis, KA Smith
Nature 268 (5616), 154-156, 1977
T cell growth factor receptors. Quantitation, specificity, and biological relevance
RJ Robb, A Munck, KA Smith
The Journal of experimental medicine 154 (5), 1455-1474, 1981
Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.
AL Moreira, EP Sampaio, A Zmuidzinas, P Frindt, KA Smith, G Kaplan
The Journal of experimental medicine 177 (6), 1675-1680, 1993
T‐cell growth factor
KA Smith
Immunological reviews 51 (1), 337-357, 1980
The interleukin-2 T-cell system: a new cell growth model
DA Cantrell, KA Smith
Science 224 (4655), 1312-1316, 1984
A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor
WJ Leonard, JM Depper, T Uchiyama, KA Smith, TA Waldmann, ...
Nature 300 (5889), 267-269, 1982
The functional relationship of the interleukins.
KA Smith, LB Lachman, JJ Oppenheim, MF Favata
The Journal of experimental medicine 151 (6), 1551-1556, 1980
Interleukin 2
KA Smith
Annual review of immunology 2 (1), 319-333, 1984
Glucocorticoid-induced inhibition of T cell growth factor production: I. The effect on mitogen-induced lymphocyte proliferation
S Gillis, GR Crabtree, KA Smith
The Journal of Immunology 123 (4), 1624-1631, 1979
Transient expression of interleukin 2 receptors. Consequences for T cell growth.
DA Cantrell, KA Smith
The Journal of experimental medicine 158 (6), 1895-1911, 1983
Interleukin 2 high-affinity receptor expression requires two distinct binding proteins.
K Teshigawara, HM Wang, K Kato, KA Smith
The Journal of experimental medicine 165 (1), 223-238, 1987
Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway.
SC Meuer, RE Hussey, DA Cantrell, JC Hodgdon, SF Schlossman, ...
Proceedings of the National Academy of Sciences 81 (5), 1509-1513, 1984
Prolonged Interleukin-2Rα Expression on Virus-Specific CD8+ T Cells Favors Terminal-Effector Differentiation In Vivo
V Kalia, S Sarkar, S Subramaniam, WN Haining, KA Smith, R Ahmed
Immunity 32 (1), 91-103, 2010
Interleukin 2 regulates its own receptors.
KA Smith, DA Cantrell
Proceedings of the National Academy of Sciences 82 (3), 864-868, 1985
The interleukin 2 receptor. Functional consequences of its bimolecular structure.
HM Wang, KA Smith
The Journal of experimental medicine 166 (4), 1055-1069, 1987
Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors.
MA Caligiuri, A Zmuidzinas, TJ Manley, H Levine, KA Smith, J Ritz
The Journal of experimental medicine 171 (5), 1509-1526, 1990
Monoclonal cytolytic T-cell lines.
PE Baker, S Gillis, KA Smith
The Journal of experimental medicine 149 (1), 273-278, 1979
The system can't perform the operation now. Try again later.
Articles 1–20